According to Frontiers in Pharmacology, the endocannabinoid system (ECS) is responsible for maintaining homeostasis and stress response (Leimuranta, Khiroug, Giniatullin, 2018).
The ECS regulates stress response, which has an impact on the central nervous system and peripheral nervous system and is responsible for reducing pain, inflammation, and alleviating neurodegenerative damage (Leimuranta, Khiroug, Giniatullin, 2018).
Due to the stabilizing effects in creating homeostasis, CBD was shown to stabilize the meninges, which are aggravated during a migraine attack and are responsible for the anti-migraine effects that can be expected following CBD administration (Leimuranta, Khiroug, Giniatullin, 2018).
The anti-inflammatory and neuroprotective properties of CBD have once again shown just how beneficial CBD is and has such a wide range of therapeutic uses (Leimuranta, Khiroug, Giniatullin, 2018).
Another study by the Cannabis and Cannabinoid Research concluded that CBD was effective in treating chronic and acute cluster headaches, chronic and acute migraines, and even people with Multiple Sclerosis (MS) trigeminal neuralgia (Lochte, Beletsky, Samuel, Grant, 2017).
That same study went on to state that CBD was effective at controlling neuropathic and chronic pain, and nausea, which all are associated with headaches (Lochte, Beletsky, Samuel, Grant, 2017).
CBD once again is stealing the dancefloor and showing off with its wide range of therapeutic uses.
Leimuranta, P., Khiroug, L., & Giniatullin, R. (2018). Emerging Role of (Endo)Cannabinoids in Migraine. Frontiers in pharmacology, 9, 420. https://doi.org/10.3389/fphar.2018.00420
Lochte, B. C., Beletsky, A., Samuel, N. K., & Grant, I. (2017). The Use of Cannabis for Headache Disorders. Cannabis and cannabinoid research, 2(1), 61–71. https://doi.org/10.1089/can.2016.0033